Maximum quantity allowed is 999
请选择数量
CAS RN: 63659-19-8 | 產品號碼: B4474
Betaxolol Hydrochloride
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | B4474 |
| 純度/分析方法 | >98.0%(HPLC) |
| 分子式 / 分子量 | C__1__8H__2__9NO__3·HCl = 343.89 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 包裝和容器 | 250MG-Glass Bottle with Plastic Insert （閲覽圖片）, 50MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 63659-19-8 |
| 相關CAS RN | 63659-18-7 |
| Reaxys-RN | 5182512 |
| PubChem Substance ID | 253662283 |
| Merck Index(14) | 1182 |
| MDL編號 | MFCD00242959 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| Melting point | 113.0 to 117.0 °C |
| NMR | confirm to structure |
性質
| 熔點 | 115 °C |
| 溶解性（微溶於） | Acetone |
| 溶解性（不溶於） | Ether |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H302 : Harmful if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
相關法規
| RTECS # | UA9823000 |
運輸資料
| HS編碼* | 2922.50-000 |
Application
Betaxolol hydrochloride: A Selective β1-Adrenoceptor Antagonist with Ca2+ Channel-Blocking Activity.
Betaxolol hydrochloride is a selective β1-adrenoceptor antagonist with Ca2+ channel-blocking activity. Betaxolol hydrochloride also has been reported as a retinal neuroprotective agent. It is used for the treatment of hypertension and glaucoma. (The product is for research purpose only.)
References
- Synthesis of a series of compounds related to betaxolol, a new β1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases
- Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension
- Betaxolol, a β1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels
- In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
- Topically applied betaxolol attenuates ischemia-induced effects to the rat retina and stimulates BDNF mRNA
- Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization
考研文獻
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。